Forbes April 30, 2024
Naveen Rao

Cryptocurrency company Tether announced an investment of $200 million into Blackrock Neurotech to take a majority stake in the Brain Computer Interface (BCI) company.

As per Reuters, “The $200m deal which closed on Friday after several months of due diligence, values Blackrock Neurotech at around $350 million, making Tether its largest shareholder.”

As a neurotech company, Blackrock has been known for their longevity, bootstrapping, and heavy reliance on public funding to drive product development. Prior to this they’d only taken on $10m in VC in 2021; this deal represents a seismic shift in the company’s history.

Here’s a brief history followed by some informed speculation about what this deal might mean for the company and the field moving forward.

Who...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
Neuralink gets FDA OK for 2nd patient
Boston Scientific's modular, wireless heart rhythm implant approach clears clinical study
Biden administration to boost tariffs on Chinese medical supplies
Pulse Biosciences names new CEO, reassigns former leader
R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee

Share This Article